Navigating FDA Fast-Track Pathways
How Needle-Free Epinephrine and Nasal Medication Innovations Move Faster In an era where severe allergic reactions and anaphylaxis demand rapid treatment, biopharma companies like Belhaven Biopharma are driving innovation in needle-free medication. The FDA’s 505(b)(2) fast-track pathway allows drug developers…